Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Hematologic Oncology Update
00:00
Epcoritamab Plus Pola and Frontline Bispecific Combinations
Neil and Matt discuss frontline trials pairing bispecifics with pola‑RCHOP and implications for high‑risk patients.
Play episode from 18:37
Transcript
